Mumbai-based Blue Jet Healthcare, a specialty pharmaceutical and healthcare ingredient and intermediate company, has filed draft red herring prospectus with market regulator.
The company will not raise any funds as the issue is completely an offer-for-sale (OFS) through which the company's promoters— Akshay Bansarilal Arora and Shiven Akshay Arora—will sell up to about 2.17 crore shares, according to the DRHP.
₹2,100-crore IPO
According to merchant banking sources, the IPO size could be in the range of ₹1,800 crore to ₹2,100 crore.
Blue Jet Healthcare is a specialty pharmaceutical and healthcare ingredient and intermediate company, operating under a contract development and manufacturing organisation (CDMO) business model. It offers niche products targeted towards innovator pharmaceutical companies and multinational generic pharmaceutical companies.
Over the past five decades, the company has developed over 100 products with over 40 products commercialised. Blue Jet operates three manufacturing facilities in Maharashtra at Shahad, Ambernath and Mahad.
Key customers
The company supplies a critical starting intermediate and several advanced intermediates to three of the largest contrast media manufacturers in the world—GE Healthcare, Guerbet and Bracco. Besides, it also supplies high-intensity sweeteners to several multi-national companies, including Colgate Palmolive (India) and Unilever, the DRHP said.
The company is a net debt-free company as on June 30, 202, according to the draft paper.
Kotak Mahindra Capital Company , ICICI Securities and JP Morgan India are the books running lead managers to the issue.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.